Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTINUATION-PV long-term follow-up after PROUD-PV
2014-001357-17Phase 3Completed
- Sponsor
- AOP Health
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropeginterferon alfa-2b in polycythemia vera (PV) (2 arms), sponsored by AOP Health. Primary endpoint: Rate of disease response. Started Aug 2014; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on 2014-001357-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001357-17.